Japan Tissue Engineering Co., Ltd.
7774.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.26 | -1.59 | -0.62 | -6.24 |
| FCF Yield | -1.21% | 0.00% | -3.77% | -1.64% |
| EV / EBITDA | -193.03 | 90.11 | -28.51 | -42.51 |
| Quality | ||||
| ROIC | -4.06% | 2.30% | -12.19% | -7.43% |
| Gross Margin | 61.55% | 67.24% | 55.92% | 59.69% |
| Cash Conversion Ratio | 0.58 | 1.91 | 0.86 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.51% | 6.13% | -3.44% | -3.07% |
| Free Cash Flow Growth | -24,032.20% | 100.12% | -133.18% | 27.74% |
| Safety | ||||
| Net Debt / EBITDA | 51.11 | -7.42 | 6.93 | 13.19 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 5.20 | 3.60 | 3.77 | 4.53 |
| Cash Conversion Cycle | 116.32 | 152.62 | 172.71 | 116.37 |